Eli Lilly gains ground with Orforglipron’s success, showing growth potential and risks from momentum and tariffs. Read why ...

Shaken by geopolitical shocks, the S&P 500 was flat last week and the Nasdaq nosed just into the red — but the Dow Jones ...

Let's look at why this news could be a game-changer for Eli Lilly and its stock.

Americans may end up paying more for their medicines as well as facing shortages of drugs they need. So it's possible there ...

We live in the gap between expectations and reality – this is a common saying that I particularly like. Employees often enter ...

China’s response to new United States (U.S.) tariffs could complicate the supply of important medicines, an analysis of data ...